Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

Saved in:
Bibliographic Details
Title: Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Authors: Pearson ADJ; ACCELERATE/ITCC, Belgium. Electronic address: andy1pearson@btinternet.com., Zwaan CM; Princess Máxima Center, Utrecht, the Netherlands; Erasmus MC, Rotterdam, the Netherlands; ITCC, the Netherlands., Kolb EA; Nemours/Alfred I. duPont Hospital for Children, USA., Karres D; European Medicines Agency, Amsterdam, the Netherlands., Guillot J; Fred Hutchinson Cancer Research Center, Leukaemia Lymphoma Society, Target Paediatric AML, USA., Kim SY; AbbVie, USA., Marshall L; Royal Marsden Hospital, The Institute of Cancer Research, UK., Tasian SK; Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, USA., Smith M; National Institutes of Health, National Cancer Institute, USA., Cooper T; Seattle Children's Hospital, USA., Adamson PC; Sanofi US, Emeritus Professor of Paediatrics & Pharmacology, Perelman School of Medicine, University of Pennsylvania, USA., Barry E; Pfizer, USA., Benettaib B; Celgene, USA., Binlich F; Servier, USA., Borgman A; Jazz Pharmaceuticals, USA., Brivio E; Princess Máxima Center, Utrecht, the Netherlands; Erasmus MC, Rotterdam, the Netherlands; ITCC, the Netherlands., Capdeville R; Novartis Pharma, Switzerland., Delgado D; Astellas Pharma Global Development, Inc., USA., Faller D; Takeda Pharmaceuticals, USA., Fogelstrand L; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Fraenkel PG; Sanofi Genzyme, USA., Hasle H; Department of Paediatrics, Aarhus University Hospital, Denmark., Heenen D; KickCancer, Belgium., Kaspers G; Princess Máxima Center, Utrecht, the Netherlands; Erasmus MC, Rotterdam, the Netherlands; ITCC, the Netherlands., Kieran M; BMS, USA., Klusmann JH; Martin Luther University Halle-Wittenberg, Germany., Lesa G; European Medicines Agency, Amsterdam, the Netherlands., Ligas F; European Medicines Agency, Amsterdam, the Netherlands., Mappa S; Helsinn Healthcare, USA., Mohamed H; FORMA Therapeutics, USA., Moore A; Queensland Children's Hospital, Brisbane, Australia., Morris J; Amgen, USA., Nottage K; Janssen Research & Development, USA., Reinhardt D; University Hospital Essen, Germany., Scobie N; Zoé4life/CCI, Denmark., Simko S; Roche/Genentech, Switzerland., Winkler T; Agios Pharmaceuticals, USA., Norga K; Universitair Ziekenhuis Antwerpen, FAMHP, Belgium., Reaman G; Food and Drug Administration, USA., Vassal G; ACCELERATE/ITCC, Belgium; Gustave Roussy Cancer Centre, France.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Sep; Vol. 136, pp. 116-129. Date of Electronic Publication: 2020 Jul 17.
Publication Type: Conference Proceedings; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32688206
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pearson+ADJ%22">Pearson ADJ</searchLink>; ACCELERATE/ITCC, Belgium. Electronic address: andy1pearson@btinternet.com.<br /><searchLink fieldCode="AU" term="%22Zwaan+CM%22">Zwaan CM</searchLink>; Princess Máxima Center, Utrecht, the Netherlands; Erasmus MC, Rotterdam, the Netherlands; ITCC, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kolb+EA%22">Kolb EA</searchLink>; Nemours/Alfred I. duPont Hospital for Children, USA.<br /><searchLink fieldCode="AU" term="%22Karres+D%22">Karres D</searchLink>; European Medicines Agency, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Guillot+J%22">Guillot J</searchLink>; Fred Hutchinson Cancer Research Center, Leukaemia Lymphoma Society, Target Paediatric AML, USA.<br /><searchLink fieldCode="AU" term="%22Kim+SY%22">Kim SY</searchLink>; AbbVie, USA.<br /><searchLink fieldCode="AU" term="%22Marshall+L%22">Marshall L</searchLink>; Royal Marsden Hospital, The Institute of Cancer Research, UK.<br /><searchLink fieldCode="AU" term="%22Tasian+SK%22">Tasian SK</searchLink>; Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Smith+M%22">Smith M</searchLink>; National Institutes of Health, National Cancer Institute, USA.<br /><searchLink fieldCode="AU" term="%22Cooper+T%22">Cooper T</searchLink>; Seattle Children's Hospital, USA.<br /><searchLink fieldCode="AU" term="%22Adamson+PC%22">Adamson PC</searchLink>; Sanofi US, Emeritus Professor of Paediatrics & Pharmacology, Perelman School of Medicine, University of Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Barry+E%22">Barry E</searchLink>; Pfizer, USA.<br /><searchLink fieldCode="AU" term="%22Benettaib+B%22">Benettaib B</searchLink>; Celgene, USA.<br /><searchLink fieldCode="AU" term="%22Binlich+F%22">Binlich F</searchLink>; Servier, USA.<br /><searchLink fieldCode="AU" term="%22Borgman+A%22">Borgman A</searchLink>; Jazz Pharmaceuticals, USA.<br /><searchLink fieldCode="AU" term="%22Brivio+E%22">Brivio E</searchLink>; Princess Máxima Center, Utrecht, the Netherlands; Erasmus MC, Rotterdam, the Netherlands; ITCC, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Capdeville+R%22">Capdeville R</searchLink>; Novartis Pharma, Switzerland.<br /><searchLink fieldCode="AU" term="%22Delgado+D%22">Delgado D</searchLink>; Astellas Pharma Global Development, Inc., USA.<br /><searchLink fieldCode="AU" term="%22Faller+D%22">Faller D</searchLink>; Takeda Pharmaceuticals, USA.<br /><searchLink fieldCode="AU" term="%22Fogelstrand+L%22">Fogelstrand L</searchLink>; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Fraenkel+PG%22">Fraenkel PG</searchLink>; Sanofi Genzyme, USA.<br /><searchLink fieldCode="AU" term="%22Hasle+H%22">Hasle H</searchLink>; Department of Paediatrics, Aarhus University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Heenen+D%22">Heenen D</searchLink>; KickCancer, Belgium.<br /><searchLink fieldCode="AU" term="%22Kaspers+G%22">Kaspers G</searchLink>; Princess Máxima Center, Utrecht, the Netherlands; Erasmus MC, Rotterdam, the Netherlands; ITCC, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kieran+M%22">Kieran M</searchLink>; BMS, USA.<br /><searchLink fieldCode="AU" term="%22Klusmann+JH%22">Klusmann JH</searchLink>; Martin Luther University Halle-Wittenberg, Germany.<br /><searchLink fieldCode="AU" term="%22Lesa+G%22">Lesa G</searchLink>; European Medicines Agency, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Ligas+F%22">Ligas F</searchLink>; European Medicines Agency, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mappa+S%22">Mappa S</searchLink>; Helsinn Healthcare, USA.<br /><searchLink fieldCode="AU" term="%22Mohamed+H%22">Mohamed H</searchLink>; FORMA Therapeutics, USA.<br /><searchLink fieldCode="AU" term="%22Moore+A%22">Moore A</searchLink>; Queensland Children's Hospital, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Morris+J%22">Morris J</searchLink>; Amgen, USA.<br /><searchLink fieldCode="AU" term="%22Nottage+K%22">Nottage K</searchLink>; Janssen Research & Development, USA.<br /><searchLink fieldCode="AU" term="%22Reinhardt+D%22">Reinhardt D</searchLink>; University Hospital Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Scobie+N%22">Scobie N</searchLink>; Zoé4life/CCI, Denmark.<br /><searchLink fieldCode="AU" term="%22Simko+S%22">Simko S</searchLink>; Roche/Genentech, Switzerland.<br /><searchLink fieldCode="AU" term="%22Winkler+T%22">Winkler T</searchLink>; Agios Pharmaceuticals, USA.<br /><searchLink fieldCode="AU" term="%22Norga+K%22">Norga K</searchLink>; Universitair Ziekenhuis Antwerpen, FAMHP, Belgium.<br /><searchLink fieldCode="AU" term="%22Reaman+G%22">Reaman G</searchLink>; Food and Drug Administration, USA.<br /><searchLink fieldCode="AU" term="%22Vassal+G%22">Vassal G</searchLink>; ACCELERATE/ITCC, Belgium; Gustave Roussy Cancer Centre, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2020 Sep; Vol. 136, pp. 116-129. <i>Date of Electronic Publication: </i>2020 Jul 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Conference Proceedings; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32688206
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2020.04.038
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 116
    Titles:
      – TitleFull: Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pearson ADJ
      – PersonEntity:
          Name:
            NameFull: Zwaan CM
      – PersonEntity:
          Name:
            NameFull: Kolb EA
      – PersonEntity:
          Name:
            NameFull: Karres D
      – PersonEntity:
          Name:
            NameFull: Guillot J
      – PersonEntity:
          Name:
            NameFull: Kim SY
      – PersonEntity:
          Name:
            NameFull: Marshall L
      – PersonEntity:
          Name:
            NameFull: Tasian SK
      – PersonEntity:
          Name:
            NameFull: Smith M
      – PersonEntity:
          Name:
            NameFull: Cooper T
      – PersonEntity:
          Name:
            NameFull: Adamson PC
      – PersonEntity:
          Name:
            NameFull: Barry E
      – PersonEntity:
          Name:
            NameFull: Benettaib B
      – PersonEntity:
          Name:
            NameFull: Binlich F
      – PersonEntity:
          Name:
            NameFull: Borgman A
      – PersonEntity:
          Name:
            NameFull: Brivio E
      – PersonEntity:
          Name:
            NameFull: Capdeville R
      – PersonEntity:
          Name:
            NameFull: Delgado D
      – PersonEntity:
          Name:
            NameFull: Faller D
      – PersonEntity:
          Name:
            NameFull: Fogelstrand L
      – PersonEntity:
          Name:
            NameFull: Fraenkel PG
      – PersonEntity:
          Name:
            NameFull: Hasle H
      – PersonEntity:
          Name:
            NameFull: Heenen D
      – PersonEntity:
          Name:
            NameFull: Kaspers G
      – PersonEntity:
          Name:
            NameFull: Kieran M
      – PersonEntity:
          Name:
            NameFull: Klusmann JH
      – PersonEntity:
          Name:
            NameFull: Lesa G
      – PersonEntity:
          Name:
            NameFull: Ligas F
      – PersonEntity:
          Name:
            NameFull: Mappa S
      – PersonEntity:
          Name:
            NameFull: Mohamed H
      – PersonEntity:
          Name:
            NameFull: Moore A
      – PersonEntity:
          Name:
            NameFull: Morris J
      – PersonEntity:
          Name:
            NameFull: Nottage K
      – PersonEntity:
          Name:
            NameFull: Reinhardt D
      – PersonEntity:
          Name:
            NameFull: Scobie N
      – PersonEntity:
          Name:
            NameFull: Simko S
      – PersonEntity:
          Name:
            NameFull: Winkler T
      – PersonEntity:
          Name:
            NameFull: Norga K
      – PersonEntity:
          Name:
            NameFull: Reaman G
      – PersonEntity:
          Name:
            NameFull: Vassal G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2020 Sep
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 136
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1